Johnson, M. L., Smit, E. F., Felip, E., Ramalingam, S. S., Ahn, M., Tsao, A., Johnson, B. E., Offin, M., Hussein, M., Dagogo-Jack, I., Goldman, J. W., Clarke, J. M., Negrao, M. V., Sanborn, R. E., Morgensztern, D., Usari, T., Wilner, K., Alejandro, L., Rifi, N., Zhang, X., Riely, G. J. (2025). Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non–Small Cell Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02023